Participants in this study were 50 patients with heart valve diseases who were 16 – 60 years old. In whom, 30 patients have arterial embolism and 20 patients have not. It was found that fibrinogen level has been increased in the patients with vascular embolism. The platelet counts have been increased and there were changes in platelet aggregation. Use of anti-coagulations such as heparin, urokinase and vitamin K provides benefits for variable disease levels if they are used with proper doses.
Heart Valve Diseases ; Heart Valves ; Platelet Aggregation